Total Payments
$17,513
2024 Payments
$2,011
Companies
22
Transactions
405
Medicare Patients
4,979
Medicare Billing
$761,661
Payment Breakdown by Category
Food & Beverage$14,360 (82.0%)
Other$1,150 (6.6%)
Consulting$950.00 (5.4%)
Travel$877.94 (5.0%)
Education$174.69 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,360 | 396 | 82.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,150 | 2 | 6.6% |
| Consulting Fee | $950.00 | 2 | 5.4% |
| Travel and Lodging | $877.94 | 3 | 5.0% |
| Education | $174.69 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $7,652 | 231 | $0 (2024) |
| Abbott Laboratories | $3,039 | 45 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,330 | 5 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,325 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,219 | 22 | $0 (2024) |
| BIOTRONIK INC. | $651.11 | 8 | $0 (2021) |
| Medtronic USA, Inc. | $500.00 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $399.92 | 24 | $0 (2023) |
| Lexicon Pharmaceuticals, Inc. | $271.15 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $224.15 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,011 | 46 | Boston Scientific Corporation ($920.95) |
| 2023 | $1,440 | 46 | Boston Scientific Corporation ($697.92) |
| 2022 | $2,624 | 60 | Abbott Laboratories ($1,264) |
| 2021 | $1,983 | 47 | SANOFI-AVENTIS U.S. LLC ($787.28) |
| 2020 | $1,238 | 26 | Boston Scientific Corporation ($740.09) |
| 2019 | $2,706 | 54 | Boston Scientific Corporation ($1,438) |
| 2018 | $2,589 | 56 | BOSTON SCIENTIFIC CORPORATION ($1,363) |
| 2017 | $2,922 | 70 | BOSTON SCIENTIFIC CORPORATION ($1,076) |
All Payment Transactions
405 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Abbott Laboratories | NA (Device) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Electrophysiology | ||||||
| 10/23/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Electrophysiology | ||||||
| 09/26/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: General - Tachy_CRM | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.02 | General |
| Category: Cardiovascular | ||||||
| 09/18/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $36.44 | General |
| Category: Electrophysiology | ||||||
| 09/18/2024 | Abbott Laboratories | NA (Device) | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: Electrophysiology | ||||||
| 09/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/03/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Electrophysiology | ||||||
| 08/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $128.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/06/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: EMBLEM_CRM | ||||||
| 07/31/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/29/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Electrophysiology | ||||||
| 07/26/2024 | Abbott Laboratories | NA (Device) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Electrophysiology | ||||||
| 07/17/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.69 | General |
| 07/12/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $67.85 | General |
| Category: Electrophysiology | ||||||
| 06/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $97.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $170.08 | General |
| 06/15/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $67.85 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 06/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $127.60 | General |
| 06/10/2024 | Abbott Laboratories | NA (Device) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Electrophysiology | ||||||
| 06/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.28 | General |
| Category: Cardiovascular | ||||||
| 06/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.85 | General |
| Category: DIABETES | ||||||
| 05/29/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.12 | General |
| 05/23/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $42.39 | General |
| Category: LUX-Dx_CRM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,320 | 2,865 | $1.4M | $144,136 |
| 2022 | 21 | 1,254 | 2,745 | $1.3M | $202,608 |
| 2021 | 23 | 1,365 | 2,842 | $1.6M | $211,576 |
| 2020 | 20 | 1,040 | 2,608 | $1.1M | $203,341 |
Total Patients
4,979
Total Services
11,060
Medicare Billing
$761,661
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 114 | 525 | $498,750 | $34,542 | 6.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 135 | 262 | $81,220 | $21,429 | 26.4% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 14 | 15 | $72,750 | $13,687 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 124 | $38,680 | $10,571 | 27.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 69 | 74 | $39,960 | $9,573 | 24.0% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 86 | 413 | $50,930 | $9,536 | 18.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 54 | 90 | $27,000 | $7,198 | 26.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 103 | 236 | $27,140 | $4,862 | 17.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 43 | 43 | $22,360 | $4,814 | 21.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 75 | 172 | $24,080 | $4,306 | 17.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 30 | 142 | $14,910 | $3,151 | 21.1% |
| 33285 | Insertion of heart rhythm monitor under skin | Facility | 2023 | 32 | 32 | $453,792 | $2,642 | 0.6% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 34 | 85 | $22,950 | $2,641 | 11.5% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 57 | 82 | $12,300 | $2,564 | 20.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 20 | 22 | $9,680 | $2,545 | 26.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 39 | 59 | $8,850 | $1,713 | 19.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $5,720 | $1,345 | 23.5% |
| 33286 | Removal of heart rhythm monitor from under the skin | Facility | 2023 | 14 | 14 | $5,166 | $1,081 | 20.9% |
| 93291 | Evaluation of cardiac rhythm monitor system | Facility | 2023 | 41 | 60 | $4,800 | $912.00 | 19.0% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Facility | 2023 | 18 | 30 | $5,400 | $890.46 | 16.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 67 | 123 | $4,920 | $879.60 | 17.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 81 | 122 | $4,880 | $857.61 | 17.6% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 38 | 38 | $3,040 | $794.20 | 26.1% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 35 | 35 | $2,975 | $758.34 | 25.5% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Facility | 2023 | 37 | 43 | $3,440 | $541.36 | 15.7% |
About Dr. Patrick Lam, MD
Dr. Patrick Lam, MD is a Cardiovascular Disease healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477538015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Lam, MD has received a total of $17,513 in payments from pharmaceutical and medical device companies, with $2,011 received in 2024. These payments were reported across 405 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($14,360).
As a Medicare-enrolled provider, Lam has provided services to 4,979 Medicare beneficiaries, totaling 11,060 services with total Medicare billing of $761,661. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location New York, NY
- Active Since 12/07/2005
- Last Updated 01/15/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1477538015
Products in Payments
- MULTAQ (Drug) $1,330
- RESONATE (Device) $1,284
- XARELTO (Drug) $1,219
- AVEIR (Device) $1,027
- EMBLEM (Device) $873.82
- JARDIANCE (Drug) $862.38
- GENERAL - THERAPIES (Device) $587.14
- Intact (Device) $500.00
- PRADAXA (Drug) $462.59
- LUX-Dx Insertable Cardiac Monitor (Device) $460.59
- GENERAL THERAPIES (Device) $460.30
- Agilis NxT EP Introducer (Device) $450.00
- ICDs (Device) $434.81
- GENERAL THERAPIES (Device) $383.32
- ENTRESTO (Drug) $334.66
- ENSITE (Device) $277.32
- ELIQUIS (Drug) $224.15
- Inpefa (Drug) $181.12
- LUX DX (Device) $180.41
- Solia (Device) $167.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in New York
Dr. Roger Hajjar, Md, MD
Cardiovascular Disease — Payments: $5.2M
Cardiovascular Disease $5.2M
Dr. Jacob Koruth, M.d, M.D
Cardiovascular Disease — Payments: $3.2M
Cardiovascular Disease $3.2M
Dr. Martin Leon, M.d, M.D
Cardiovascular Disease — Payments: $2.7M
Cardiovascular Disease $2.7M
Dr. Gregg Stone, M.d, M.D
Cardiovascular Disease — Payments: $2.2M
Cardiovascular Disease $2.2M
Adam Rosenbluth, Md, MD
Cardiovascular Disease — Payments: $1.5M
Cardiovascular Disease $1.5M
Dr. Deepak Bhatt, Md, MD
Cardiovascular Disease — Payments: $1.4M
Cardiovascular Disease $1.4M